Jaguar Health, Inc. · Drugmakers

JAGX

High riskNext report: Around Nov 19 (est.)

View price ↗

The short version

A company still losing money with shrinking sales, with high risk.

Watch out for

Sales down 59% in the latest quarter vs a year ago
Late quarterly report notice
Less than a month of cash left at its current burn

Money moves

No insider buying or selling in the last 30 days

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$2.34+14.7% that day

Company value: $401M; Share price times all shares
Price vs sales: 14.4x; No profit over the last year, so this compares value with sales instead
Cash vs value: 1%; Cash as a share of company value
Debt vs value: 11%; Debt as a share of company value

From JAGX's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$1.2M-59% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $27.8M, up 136% from the 12 months before. Over 5 years, sales grew about 4.2% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of JAGX. Starting points are the company's recent numbers.

Sales growth+4% a yearRecently: +4.2% a yearProfit margin50%Last 12 months: 60.2%P/E at the end15xMany steady companies trade at 12x to 25xShare count change+10% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$34M

Profit in 5 years$17M

Price these guesses point to$0.92-61% vs $2.34 todayAbout -17% a year, before dividends

What today's price needs: with a 50% margin and a 15x P/E, sales would have to grow about 25% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

0/4Weak

MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.-0.5%
MissProfitable every yearSteady profits, not one good year.0 of 10 years
MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$23.7M
MissShare count not growingNot diluting owners. Falling means buybacks.+77.8% in 3 years

Revenue: $11.5M; -1.5% vs prior year
5-year growth: +4.2%/yr; revenue, per year
Total debt: $42.5M
Current ratio: 0.50x; short-term assets / bills due

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: return on equity 15%+, debt under half of equity, gross margin 40%+. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Jun 30, 2026

Reported Aug 19

Revenue: $1.2M; -58.9% YoY
EPS: -$15.70; vs -$1076.82
Op. margin: -620.2%; -351.4 pts
Gross margin: 15.8%; -66.5 pts
Free cash flow: -$5.3M
Share count: +8271.7%; vs a year ago

Insider rating

Last 90 days

No open-market insider buys or sells in the last 90 days.

Weekly insider trend

No trades to chart yet.

Filing buzz

Last 7 days vs normal

32/ 100

This week: 1
Normal week: 2.0
vs normal: 0.5x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Steady

The share count changed with a stock split this quarter, so the change in holdings isn't comparable until next quarter.

Shares held by institutions5K

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

+187.5%

Cash runwayAt last year's cash burn

2 months

Debt to equityLatest balance sheet: debt compared with what owners have

3.2x · $15.6M debt

Shares outstandingLatest reported

171M

Why high risk

Losing money, losses are large next to sales
About 2 months of cash left at its current burn
Share count growing 187.5% a year (dilution)
High debt: 3.16x equity
Bills due within a year exceed short-term assets
17 offering filings in 6 months (may sell new shares)
Late quarterly report notice
Exchange listing notice (a delisting warning or a move to another exchange)
Late annual report notice

Earnings reports

Last 12

Next reportAround Nov 19 (est.)Estimated from the same quarter last year

Results filedAug 19
Results filedMay 20
Results filedApr 7
Results filedMay 15, 2025
Results filedMar 31, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

Insider trades

Open-market buys and sells, last 90 days

No open-market buys or sells in 90 days. Grants and option exercises are left out.

"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.

Latest filings

Straight from SEC EDGAR

Shelf offering registrationOct 22 · Form S-3 ↗Proxy statementOct 8 · Form DEF 14A ↗Major agreementOct 5 · Form 8-K ↗PRER14ASep 29 · Form PRER14A ↗Major agreementSep 28 · Form 8-K ↗Major agreementSep 25 · Form 8-K ↗Major agreementSep 24 · Form 8-K ↗Offering prospectusSep 24 · Form 424B5 ↗5%+ holder update (passive)Sep 24 · Form SCHEDULE 13G/A ↗Charter or share changeSep 21 · Form 8-K ↗PRE 14ASep 18 · Form PRE 14A ↗Charter or share changeSep 15 · Form 8-K ↗Major agreementSep 15 · Form 8-K ↗Other company newsSep 4 · Form 8-K ↗Offering prospectusSep 3 · Form 424B5 ↗

Source: SEC EDGAR filings. For informational purposes. Not investment advice.

Report a problem with this page